Search by Drug Name or NDC

    NDC 51672-4043-03 Clorazepate Dipotassium 7.5 mg/1 Details

    Clorazepate Dipotassium 7.5 mg/1

    Clorazepate Dipotassium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is CLORAZEPATE DIPOTASSIUM.

    Product Information

    NDC 51672-4043
    Product ID 51672-4043_a22613cd-20d8-4b29-8520-d66368b47ea0
    Associated GPIs 57100030100310
    GCN Sequence Number 003746
    GCN Sequence Number Description clorazepate dipotassium TABLET 7.5 MG ORAL
    HIC3 H20
    HIC3 Description ANTI-ANXIETY - BENZODIAZEPINES
    GCN 14093
    HICL Sequence Number 001612
    HICL Sequence Number Description CLORAZEPATE DIPOTASSIUM
    Brand/Generic Generic
    Proprietary Name Clorazepate Dipotassium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clorazepate Dipotassium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 7.5
    Active Ingredient Units mg/1
    Substance Name CLORAZEPATE DIPOTASSIUM
    Labeler Name Taro Pharmaceuticals U.S.A., Inc.
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA075731
    Listing Certified Through 2024-12-31

    Package

    NDC 51672-4043-03 (51672404303)

    NDC Package Code 51672-4043-3
    Billing NDC 51672404303
    Package 1000 TABLET in 1 BOTTLE (51672-4043-3)
    Marketing Start Date 2000-04-27
    NDC Exclude Flag N
    Pricing Information N/A